Location: Home
  • search
  • go
  • Relate News
  • 2/24/2026GenSci Advances PD-1 Agonist Into Phase 2b for Rheumatoid Arthritis
  • 2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...
  • 2/24/2026CDE Issues Guideline on Clinical Information for CAR-T Therapy Package...
  • 2/24/2026CDE Releases Q&A Document on Development Safety Update Reports
  • 2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...
  • 2/24/2026China Prepares to Implement Landmark Regulations for Clinical Research...
  • 2/24/2026Biokin's Iza-Bren Achieves Second Phase III Survival Success in China ...
  • 2/24/2026After 230% Deal Size Explosion, China Is No Longer the 'Bargain Baseme...
  • 2/21/2026Hansoh Pharma's Ameile Wins EU Approval for EGFR-Mutant Lung Cancer
  • 2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought
  • 2/20/2026CSPC's Long-Acting SYH2082 Clears FDA to Begin Clinical Trials
  • 2/20/2026China Biotech Kicks Off 2026 with $863 Million in January Raises
  • 2/16/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...
  • 2/16/2026Long-Acting Obesity Drugs Drive Record January Licensing Boom for Chin...
  • 2/16/2026CStone's Trispecific Antibody CS2009 Receives FDA IND Clearance, Ente...
  • 2/16/2026FindCure Secures CNY 100M+ Series B to Accelerate Cancer Therapy Progr...
  • 2/16/2026CSPC's Long-Acting Ropivacaine Injection Cleared for Clinical Trials i...
  • 2/14/2026Recordati to Withdraw from China After Rare Disease Portfolio Underper...
  • 2/13/2026Gilead Acquires Global Rights to Genhouse Oral Cancer Drug With $80 Mi...
  • 2/13/2026Pentagon Reverses Decision After Briefly Listing WuXi AppTec as Chines...
  • 2/13/2026Salubris Files Hong Kong IPO to Expand Cardiovascular-Kidney-Metabolic...
  • 2/13/2026VivaVision Files Hong Kong IPO to Fund Late-Stage Ophthalmology Progra...
  • 2/13/2026ProteLight Pharmaceuticals Files Hong Kong IPO application
  • 2/13/2026Shenzhen Immunofoco Biotechnology files Hong Kong IPO application
  • 2/13/2026China Biotech Dealmaking and Financing Stay Strong in January 2026 Des...
  • 2/12/2026Today's China Crucible: What It Means for Pharma (PharmExec)
  • 2/12/2026China NMPA Approves Nine New Drugs in January 2026, Expanding Beyond O...
  • 2/12/2026China Indicts AstraZeneca and Former China Head Leon Wang Over Data an...
  • 2/12/2026UniXell Raises Over CNY 50M in Series A+ to Advance Stem Cell Therapy ...
  • 2/12/2026Lilly China's Mounjaro Approved for Type 2 Diabetes Monotherapy
  • Page:11/828 Total number of articles:24826: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group